Wanbangde Pharmaceutical Holding Group Co Ltd (002082) — Working Capital to Net Assets Ratio

Latest as of March 2026: 12.9%

Wanbangde Pharmaceutical Holding Group Co Ltd (002082) has a Working Capital to Net Assets ratio of 12.9% as of March 2026. Working capital of CN¥347.43 Million (current assets of CN¥1.84 Billion minus current liabilities of CN¥1.49 Billion) is measured against net assets of CN¥2.70 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Wanbangde Pharmaceutical Holding Group C (002082) net asset quality to measure how much of total assets are equity-financed.

WC/NA Ratio

12.9%
Working Capital / Net Assets

Working Capital

CN¥347.43 Million
CNY

Current Assets

CN¥1.84 Billion
CNY

Current Liabilities

CN¥1.49 Billion
CNY

Wanbangde Pharmaceutical Holding Group Co Ltd Working Capital to Net Assets (2003–2025)

This chart shows how Wanbangde Pharmaceutical Holding Group Co Ltd's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2003 to 2025. As of March 2026, the ratio stands at 12.9%, reflecting working capital of CN¥347.43 Million against net assets of CN¥2.70 Billion CNY. Check tangible equity quality of Wanbangde Pharmaceutical Holding Group C to evaluate the tangible quality of the company's equity base.

Annual Working Capital to Net Assets for Wanbangde Pharmaceutical Holding Group Co Ltd (2003–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Wanbangde Pharmaceutical Holding Group Co Ltd from 2003 to 2025, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Wanbangde Pharmaceutical Holding Group C worth.

Year WC/NA Ratio Working Capital (CNY) Net Assets Current Assets Current Liabilities Change (pp)
2025 11.6% CN¥303.45 Million CN¥2.61 Billion CN¥1.65 Billion CN¥1.35 Billion ▼ -6.0 pp
2024 17.7% CN¥487.05 Million CN¥2.76 Billion CN¥1.80 Billion CN¥1.32 Billion ▼ -4.0 pp
2023 21.6% CN¥596.66 Million CN¥2.76 Billion CN¥1.92 Billion CN¥1.33 Billion ▼ -16.1 pp
2022 37.7% CN¥1.06 Billion CN¥2.82 Billion CN¥2.20 Billion CN¥1.14 Billion ▼ -5.5 pp
2021 43.2% CN¥1.19 Billion CN¥2.74 Billion CN¥2.47 Billion CN¥1.28 Billion ▲ +0.6 pp
2020 42.6% CN¥1.22 Billion CN¥2.86 Billion CN¥3.08 Billion CN¥1.87 Billion ▼ -8.7 pp
2019 51.3% CN¥980.28 Million CN¥1.91 Billion CN¥2.19 Billion CN¥1.21 Billion ▲ +20.0 pp
2018 31.3% CN¥538.74 Million CN¥1.72 Billion CN¥1.63 Billion CN¥1.09 Billion ▼ -16.8 pp
2017 48.1% CN¥770.68 Million CN¥1.60 Billion CN¥1.24 Billion CN¥466.58 Million ▼ -19.1 pp
2016 67.1% CN¥937.52 Million CN¥1.40 Billion CN¥1.19 Billion CN¥251.23 Million ▲ +4.6 pp
2015 62.5% CN¥842.30 Million CN¥1.35 Billion CN¥1.10 Billion CN¥256.55 Million ▲ +2.3 pp
2014 60.2% CN¥780.33 Million CN¥1.30 Billion CN¥1.02 Billion CN¥240.91 Million ▲ +4.1 pp
2013 56.0% CN¥665.79 Million CN¥1.19 Billion CN¥1.01 Billion CN¥344.89 Million ▲ +9.7 pp
2012 46.4% CN¥509.16 Million CN¥1.10 Billion CN¥959.09 Million CN¥449.93 Million ▲ +3.8 pp
2011 42.6% CN¥448.61 Million CN¥1.05 Billion CN¥822.92 Million CN¥374.30 Million ▲ +0.3 pp
2010 42.3% CN¥395.88 Million CN¥936.13 Million CN¥755.87 Million CN¥359.99 Million ▲ +14.0 pp
2009 28.3% CN¥229.47 Million CN¥811.59 Million CN¥527.60 Million CN¥298.14 Million ▲ +6.2 pp
2008 22.0% CN¥156.90 Million CN¥712.31 Million CN¥456.37 Million CN¥299.46 Million ▲ +24.0 pp
2007 -2.0% CN¥-8.39 Million CN¥415.12 Million CN¥478.32 Million CN¥486.71 Million ▼ -10.2 pp
2006 8.2% CN¥29.19 Million CN¥357.72 Million CN¥499.94 Million CN¥470.75 Million ▲ +95.6 pp
2005 -87.4% CN¥-133.62 Million CN¥152.88 Million CN¥345.23 Million CN¥478.84 Million ▼ -69.2 pp
2004 -18.2% CN¥-24.72 Million CN¥136.17 Million CN¥178.44 Million CN¥203.16 Million ▼ -4.9 pp
2003 -13.3% CN¥-13.09 Million CN¥98.53 Million CN¥111.87 Million CN¥124.97 Million
pp = percentage points